I have invested across both public and private markets, with a focus on long-term value creation and real-world impact. My approach is shaped by my expertise at the intersection of medicine, technology and innovation, with a bias towards secular compounders benefiting from structural tailwinds.
My involvement ranges from passive investment to more engaged, advisory-style participation, depending on alignment, stage, and opportunity. I value thoughtful teams, clarity of vision, and a long-term mindset.
I am always interested in thoughtful discussions around long-term investing and emerging ideas.